Sight Sciences (SGHT) News Today $3.61 +0.17 (+4.94%) Closing price 04:00 PM EasternExtended Trading$3.62 +0.01 (+0.28%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGHT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period D. E. Shaw & Co. Inc. Acquires 88,738 Shares of Sight Sciences, Inc. (NASDAQ:SGHT)D. E. Shaw & Co. Inc. increased its stake in Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 27.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 410,325 shares of the company's stock after purchasing an additional 88,738 shares duMay 25 at 3:36 AM | marketbeat.comCitigroup Reaffirms Neutral Rating for Sight Sciences (NASDAQ:SGHT)May 24, 2025 | americanbankingnews.comJacobs Levy Equity Management Inc. Sells 135,268 Shares of Sight Sciences, Inc. (NASDAQ:SGHT)Jacobs Levy Equity Management Inc. cut its stake in Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 65.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,625 shares of the company's stock after selling 135May 21, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) versus Merit Medical Systems (NASDAQ:MMSI) Financial SurveyMay 20, 2025 | americanbankingnews.comSight Sciences, Inc. (NASDAQ:SGHT) Shares Purchased by Dimensional Fund Advisors LPDimensional Fund Advisors LP increased its stake in shares of Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 79.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 243,954 shares of the company's stockMay 18, 2025 | marketbeat.comProsight Management LP Acquires 377,625 Shares of Sight Sciences, Inc. (NASDAQ:SGHT)Prosight Management LP raised its holdings in Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 71.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 908,847 shares of the company's stock after buying an additional 377,May 17, 2025 | marketbeat.comSight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27thMay 14, 2025 | globenewswire.comBrokers Set Expectations for Sight Sciences Q1 EarningsSight Sciences, Inc. (NASDAQ:SGHT - Free Report) - Research analysts at William Blair issued their Q1 2026 earnings estimates for Sight Sciences in a research note issued on Friday, May 9th. William Blair analyst M. Andrew forecasts that the company will earn ($0.27) per share for the quarter. ThMay 13, 2025 | marketbeat.comSight Sciences stock holds as Needham reiterates ratingMay 11, 2025 | uk.investing.comSight Sciences, Inc. (SGHT) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comSight Sciences, Inc. (NASDAQ:SGHT) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comSight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue GuidanceMay 10, 2025 | finance.yahoo.comSight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of "Hold" from AnalystsShares of Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) have earned an average rating of "Hold" from the seven ratings firms that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendationMay 6, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by Renaissance Technologies LLCRenaissance Technologies LLC raised its holdings in Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 654.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 393,006 shares of the company's stock after buying an additional 340,906 shares dApril 30, 2025 | marketbeat.comSight Sciences (SGHT) to Release Earnings on ThursdaySight Sciences (NASDAQ:SGHT) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-sight-sciences-inc-stock/)April 26, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Shares Bought by Long Focus Capital Management LLCLong Focus Capital Management LLC lifted its position in shares of Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 158.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,238,632 shares of theApril 25, 2025 | marketbeat.comSight Sciences appoints new board memberApril 24, 2025 | investing.comSight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025April 24, 2025 | globenewswire.comSight Sciences Announces the Release of its Sustainability ReportApril 23, 2025 | globenewswire.comB Group Inc. Buys Shares of 629,370 Sight Sciences, Inc. (NASDAQ:SGHT)B Group Inc. purchased a new position in shares of Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 629,370 shares of the company's stock, valued aApril 23, 2025 | marketbeat.comSight Sciences Launches OMNI® Edge Surgical System to Enhance Glaucoma TreatmentApril 23, 2025 | nasdaq.comSight Sciences Appoints Gary Burbach to its Board of DirectorsApril 22, 2025 | globenewswire.comSight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product PortfolioApril 21, 2025 | globenewswire.comSight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Recommendation of "Hold" by AnalystsSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) has been given an average rating of "Hold" by the seven research firms that are covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1April 12, 2025 | marketbeat.comNeedham & Company LLC Reiterates Hold Rating for Sight Sciences (NASDAQ:SGHT)Needham & Company LLC restated a "hold" rating on shares of Sight Sciences in a report on Wednesday.April 11, 2025 | marketbeat.comNeedham Sticks to Its Hold Rating for Sight Sciences (SGHT)April 10, 2025 | markets.businessinsider.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $11,647.02 in StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) insider Matthew Link sold 5,042 shares of the stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $2.31, for a total value of $11,647.02. Following the sale, the insider now owns 830,551 shares of the company's stock, valued at $1,918,572.81. This trade represents a 0.60 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.April 5, 2025 | marketbeat.comDavid Badawi Sells 5,980 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CTO David Badawi sold 5,980 shares of the stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $2.30, for a total value of $13,754.00. Following the completion of the transaction, the chief technology officer now owns 1,836,704 shares in the company, valued at approximately $4,224,419.20. The trade was a 0.32 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.April 5, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) CEO Paul Badawi Sells 24,174 SharesSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CEO Paul Badawi sold 24,174 shares of the firm's stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $2.30, for a total value of $55,600.20. Following the sale, the chief executive officer now owns 6,010,580 shares in the company, valued at $13,824,334. The trade was a 0.40 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.April 5, 2025 | marketbeat.comShort Interest in Sight Sciences, Inc. (NASDAQ:SGHT) Increases By 22.4%Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 1,910,000 shares, a growth of 22.4% from the February 28th total of 1,560,000 shares. Approximately 6.7% of the company's stock are short sold. Based on an average daily trading volume, of 265,500 shares, the short-interest ratio is currently 7.2 days.April 4, 2025 | marketbeat.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells 5,042 Shares of StockApril 4, 2025 | insidertrades.comJackson Square Partners LLC Reduces Position in Sight Sciences, Inc. (NASDAQ:SGHT)Jackson Square Partners LLC lowered its stake in Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) by 74.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 230,997 shares of the company's stock after selliMarch 26, 2025 | marketbeat.comSight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8thMarch 25, 2025 | globenewswire.comInsider Buying: Sight Sciences, Inc. (NASDAQ:SGHT) EVP Purchases 10,000 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) EVP Manohar K. Raheja bought 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 12th. The stock was acquired at an average price of $2.73 per share, for a total transaction of $27,300.00. Following the transaction, the executive vice president now owns 145,000 shares in the company, valued at $395,850. This trade represents a 7.41 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.March 14, 2025 | marketbeat.comManohar K. Raheja Acquires 10,000 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) StockMarch 14, 2025 | insidertrades.comSight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 GuidanceMarch 7, 2025 | nasdaq.comLake Street Capital Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $2.50Lake Street Capital reduced their target price on shares of Sight Sciences from $3.00 to $2.50 and set a "hold" rating on the stock in a report on Thursday.March 7, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Given New $4.00 Price Target at Stifel NicolausStifel Nicolaus reduced their target price on shares of Sight Sciences from $5.00 to $4.00 and set a "buy" rating on the stock in a report on Thursday.March 7, 2025 | marketbeat.comPiper Sandler Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $3.50Piper Sandler reduced their target price on shares of Sight Sciences from $5.50 to $3.50 and set a "neutral" rating on the stock in a research note on Thursday.March 7, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Receives "Hold" Rating from Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Sight Sciences in a report on Thursday.March 7, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Announces Quarterly Earnings ResultsSight Sciences (NASDAQ:SGHT - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.01). Sight Sciences had a negative net margin of 63.30% and a negative return on equity of 47.28%.March 6, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | msn.comSight Sciences price target lowered to $3.50 from $5.50 at Piper SandlerMarch 6, 2025 | markets.businessinsider.comSight Sciences (SGHT) Receives a Hold from Piper SandlerMarch 6, 2025 | markets.businessinsider.comSight Sciences Reports 2024 Results and 2025 OutlookMarch 5, 2025 | tipranks.comSight Sciences, Inc. (SGHT) Q4 2024 Earnings Conference Call TranscriptMarch 5, 2025 | seekingalpha.comSight Sciences sees FY25 revenue $70M-$75M, consensus $78.07MMarch 5, 2025 | markets.businessinsider.comSight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial GuidanceMarch 5, 2025 | globenewswire.comCitigroup Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $3.00Citigroup decreased their price objective on shares of Sight Sciences from $4.60 to $3.00 and set a "neutral" rating for the company in a research note on Tuesday.March 5, 2025 | marketbeat.comSight Sciences Inc SGHTMarch 4, 2025 | morningstar.com Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address SGHT Media Mentions By Week SGHT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGHT News Sentiment▼1.240.93▲Average Medical News Sentiment SGHT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGHT Articles This Week▼43▲SGHT Articles Average Week Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RXST News BBNX News CBLL News DCTH News AVNS News BFLY News BVS News KIDS News NPCE News AXGN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGHT) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
